Moderna Inc

NASDAQ:MRNA 4:00:00 PM EDT

103.29

+3.02 (+3.01%)

4:20:27 PM EDT: $103.72 +0.43 (+0.42%)

Market Cap (Intraday)	39.31B
Current PE	32.57
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.6 Billion
Adjusted EPS	-$1.61

See more estimates

10-Day MA	$102.16
50-Day MA	$108.62
200-Day MA	$140.28

See more pivots

Moderna Inc Stock, NASDAQ:MRNA

200 Technology Square, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.714.6500

Number of Employees: 3900

http://www.modernatx.com

Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.